|
|
||||||||
1 Renal Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; 2 Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta T2N 4N1; and 3 Banting and Best Department for Medical Research, University of Toronto, Toronto, Ontario, Canada M5G 1L6
The sarcoplasmic (or endoplasmic) reticulum Ca2+-ATPase (SERCA)-3 has been implicated in the possible dysregulation of Ca2+ homeostasis that accompanies the pathology of hypertension and diabetes. We report the molecular cloning of two alternatively spliced transcripts from the human SERCA3 gene, ATP2A3, that encode proteins that differ at their carboxy termini by 36 amino acids. SERCA3 transcripts were most abundantly expressed in lymphoid tissues, intestine, pancreas, and prostate. The two human SERCA3 proteins encoded by alternatively spliced transcripts were recognized by the monoclonal antibody PL/IM430 and demonstrated Ca2+ uptake and ATPase activity with an apparent Ca2+ affinity 0.5 pCa unit lower than that of other SERCA gene products. The subcellular distribution of SERCA3 protein was indistinguishable from that of SERCA2b, with expression in the nuclear envelope and in the endoplasmic reticulum throughout the cell. Two variant SERCA3 constructs, huS3-I and huS3-II, were isolated that encode proteins with three amino acid differences: Ala-673 (in huS3-I) substituted for Thr (in huS3-II), Ile-817 substituted for Met, and an insertion of Glu-994. huS3-I displayed a 10-fold lower capacity to transport Ca2+ than huS3-II.
molecular cloning; calcium-adenosinetriphosphatase; Jurkat T cells; kidney
This article has been cited by other articles:
![]() |
R. Rizzuto and T. Pozzan Microdomains of Intracellular Ca2+: Molecular Determinants and Functional Consequences Physiol Rev, January 1, 2006; 86(1): 369 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Chandrasekera and J. Lytton Inhibition of Human SERCA3 by PL/IM430. MOLECULAR ANALYSIS OF THE INTERACTION J. Biol. Chem., March 28, 2003; 278(14): 12482 - 12488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arredouani, Y. Guiot, J.-C. Jonas, L. H. Liu, M. Nenquin, J. A. Pertusa, J. Rahier, J.-F. Rolland, G. E. Shull, M. Stevens, et al. SERCA3 Ablation Does Not Impair Insulin Secretion but Suggests Distinct Roles of Different Sarcoendoplasmic Reticulum Ca2+ Pumps for Ca2+ Homeostasis in Pancreatic {beta}-cells Diabetes, November 1, 2002; 51(11): 3245 - 3253. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-D. Wu, D. Bungard, and J. Lytton Regulation of SERCA Ca2+ pump expression by cytoplasmic [Ca2+] in vascular smooth muscle cells Am J Physiol Cell Physiol, April 1, 2001; 280(4): C843 - C851. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Corbett, K. M. Michalak, K. Oikawa, S. Johnson, I. D. Campbell, P. Eggleton, C. Kay, and M. Michalak The Conformation of Calreticulin Is Influenced by the Endoplasmic Reticulum Luminal Environment J. Biol. Chem., August 25, 2000; 275(35): 27177 - 27185. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mitchell-Felton, R. B. Hunter, E. J. Stevenson, and S. C. Kandarian Identification of Weight-bearing-responsive Elements in the Skeletal Muscle Sarco(endo)plasmic Reticulum Ca2+ ATPase (SERCA1) Gene J. Biol. Chem., July 21, 2000; 275(30): 23005 - 23011. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |